Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ocugen, Inc. Director's Dealing 2019

Oct 4, 2019

32915_dirs_2019-10-04_058d40be-54d2-4e5e-9256-5e79a13b1421.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-27

Reporting Person: Zhang Junge (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 212863 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants (Right to Buy) $2.77 2025-01-10 Common Stock (143820) Indirect
Warrants (Right to Buy) $7.56 2027-06-12 Common Stock (1653) Indirect